FDA Issues Broad Exemptions to Extend Deadline for Supply Chain Security Measures 
By

By
Responding to stakeholders across the pharmaceutical supply chain, the US Food and Drug Administration (FDA) announced it will provide additional time to meet enhanced distribution security requirements under the Drug…

Baxter Provides Update on North Carolina Mfg Facility Damaged by Hurricane Helene 
By

By
Baxter, a medical technology and healthcare company, has provided an update on its North Cove, North Carolina, injectables manufacturing facility, which was flooded and severely impacted by the rain and…

Lilly Appoints Its First Chief AI Officer 
By

By
Eli Lilly and Company has announced the appointment of Thomas J. Fuchs as its first Chief AI officer, effective October. 21, 2024. In this role, Fuchs will provide vision, strategic…

Supplier News: Simtra, Kindeva & MilliporeSigma 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Simtra BioPharma Solutions, Kindeva Drug Delivery and MilliporeSigma.   Formulation Development/Drug Product Manufacturing * Simtra BioPharma Investing $14 M In ADC Conjugation & Purification…

Lilly Investing $4.5 Bn In Advanced Mfg & Drug Development Center 
By

By
Eli Lilly and Company has announced a $4.5-billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development.   The facility will give Lilly the…

J&J Investing $2 Bn for New Biomanufacturing Facility in North Carolina 
By

By
Johnson & Johnson (J&J) has announced an investment of more than $2 billion to build a biologics manufacturing facility in Wilson, North Carolina.   J&J says the new facility is part…

Lonza Completes $1.2-Bn Acquisition of Biologics Mfg Facility from Roche 
By

By
Lonza has completed its $1.2-billion acquisition of a large-scale biologics manufacturing site in Vacaville, California, from Roche’s Genentech. The deal was announced in March 2024.  The Vacaville facility has a…

SK pharmteco Investing $260 M in New Small-Molecule & Peptide Mfg Facility 
By

By
SK pharmteco, a Rancho Cordova, California-based CDMO of small-molecule active pharmaceutical ingredients and cell and gene therapies, has announced an investment of $260 million to construct a new facility in…

Supplier News: Afton, Piramal, Lonza & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Afton Scientific, Piramal Pharma Solutions, Lonza, Recipharm, Exela, Almac, KD Pharma and dsm-firmenich.   Formulation Development/Drug Product Manufacturing * Afton Scientific Investing $200 M…

Pfizer Withdraws Sickle-Cell Disease Drug Globally 
By

By
Pfizer has voluntarily suspended marketing of its sickle-cell drug, Oxbryta (voxelotor), on a global basis based on a clinical benefit–risk assessment. The company had acquired the drug as part of…